Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
1/29/15 Intercept (ICPT) INT-747 for Non-alcoholic Steatohepatitis (NASH) Subscribers Only Subscribers Only Subscribers Only
1/29/15 Shire (SHPG) Firazyr for Drug-induced Angioedema Subscribers Only Subscribers Only Subscribers Only
1/29/15 Pharmacyclics (PCYC) Imbruvica for Waldenstrom Macroglobulinemia (WM) / Lymphoplasmacytic Lymphoma (LPL) - NHL Subscribers Only Subscribers Only Subscribers Only
1/29/15 Synergy (SGYP) Plecanatide for Chronic Idiopathic Constipation Subscribers Only Subscribers Only Subscribers Only
1/28/15 Serendex Molgramostim for Pulmonary Alveolar Proteinosis (PAP) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
Now - 01/30/15 Subscribers Only Subscribers Only Trial Data - Top-Line Results
Now - 01/30/15 Subscribers Only Subscribers Only Trial Announcement - Initiation
Now - 01/30/15 Subscribers Only Subscribers Only Trial Announcement - Hold Lifted
Now - 01/30/15 Subscribers Only Subscribers Only Regulatory - Meeting with FDA
Now - 01/30/15 Subscribers Only Subscribers Only Regulatory - Meeting with FDA